Your browser doesn't support javascript.
loading
Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
Kumar, Jitendra; Yadav, Viveka Nand; Phulera, Swastik; Kamble, Ashish; Gautam, Avneesh Kumar; Panwar, Hemendra Singh; Sahu, Arvind.
Afiliação
  • Kumar J; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India.
  • Yadav VN; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India.
  • Phulera S; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India.
  • Kamble A; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India.
  • Gautam AK; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India.
  • Panwar HS; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India.
  • Sahu A; Complement Biology Laboratory, National Centre for Cell Science, S. P. Pune University, Ganeshkhind, Pune, India arvindsahu@nccs.res.in.
J Virol ; 91(19)2017 10 01.
Article em En | MEDLINE | ID: mdl-28724763
Poxviruses display species tropism-variola virus is a human-specific virus, while vaccinia virus causes repeated outbreaks in dairy cattle. Consistent with this, variola virus complement regulator SPICE (smallpox inhibitor of complement enzymes) exhibits selectivity in inhibiting the human alternative complement pathway and vaccinia virus complement regulator VCP (vaccinia virus complement control protein) displays selectivity in inhibiting the bovine alternative complement pathway. In the present study, we examined the species specificity of VCP and SPICE for the classical pathway (CP). We observed that VCP is ∼43-fold superior to SPICE in inhibiting bovine CP. Further, functional assays revealed that increased inhibitory activity of VCP for bovine CP is solely due to its enhanced cofactor activity, with no effect on decay of bovine CP C3-convertase. To probe the structural basis of this specificity, we utilized single- and multi-amino-acid substitution mutants wherein 1 or more of the 11 variant VCP residues were substituted in the SPICE template. Examination of these mutants for their ability to inhibit bovine CP revealed that E108, E120, and E144 are primarily responsible for imparting the specificity and contribute to the enhanced cofactor activity of VCP. Binding and functional assays suggested that these residues interact with bovine factor I but not with bovine C4(H2O) (a moiety conformationally similar to C4b). Mapping of these residues onto the modeled structure of bovine C4b-VCP-bovine factor I supported the mutagenesis data. Taken together, our data help explain why the vaccine strain of vaccinia virus was able to gain a foothold in domesticated animals.IMPORTANCE Vaccinia virus was used for smallpox vaccination. The vaccine-derived virus is now circulating and causing outbreaks in dairy cattle in India and Brazil. However, the reason for this tropism is unknown. It is well recognized that the virus is susceptible to neutralization by the complement classical pathway (CP). Because the virus encodes a soluble complement regulator, VCP, we examined whether this protein displays selectivity in targeting bovine CP. Our data show that it does exhibit selectivity in inhibiting the bovine CP and that this is primarily determined by its amino acids E108, E120, and E144, which interact with bovine serine protease factor I to inactivate bovine C4b-one of the two subunits of CP C3-convertase. Of note, the variola complement regulator SPICE contains positively charged residues at these positions. Thus, these variant residues in VCP help enhance its potency against the bovine CP and thereby the fitness of the virus in cattle.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD Problema de saúde: 4_smallpox Assunto principal: Proteínas Virais / Proteínas da Matriz Viral / Ativação do Complemento / Via Alternativa do Complemento / Via Clássica do Complemento / Tropismo Viral Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD Problema de saúde: 4_smallpox Assunto principal: Proteínas Virais / Proteínas da Matriz Viral / Ativação do Complemento / Via Alternativa do Complemento / Via Clássica do Complemento / Tropismo Viral Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia
...